| 臺大學術典藏 |
2021-02-02T00:43:00Z |
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; Lan K.-H.; HONG-JENG YU; Lai M.-K.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:00Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.;Huang C.-Y.;Hou W.-H.;Wang C.-C.;Lan K.-H.;Chen C.-H.;Hong-Jeng Yu;Lai M.-K.;Cheng A.-L.;Liu S.-P.;Pu Y.-S.;Cheng J.C.-H.; Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; Lan K.-H.; Chen C.-H.; HONG-JENG YU; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:01Z |
Assessment of ketamine uropathy
|
Yang S.S.;Wu C.-H.;Chen J.Y.J.;Chang S.-J.;Jang M.Y.;Wu W.J.;Ruan Y.S.;Li S.Y.;Wu J.S.;Chung Y.C.;Li W.J.;Li Y.H.;Tang Y.C.;Shen K.H.;Lin W.Y.;Chen J.S.;Lee M.H.;Chen M.H.;Zou J.L.;Jhang J.S.;Syu J.S.;Yang S.S.;Chang S.J.;Lin A.T.L.;Fan Y.H.;Meng E.;Syu Y.J.;Hong-Jeng Yu;Guo Y.C.;Ye J.S.;Wang Y.J.;Jhang J.F.;Jiang Y.H.;Kuo H.C.;Team For National Registration Of Ketamine Uropathy; Yang S.S.; Wu C.-H.; Chen J.Y.J.; Chang S.-J.; Jang M.Y.; Wu W.J.; Ruan Y.S.; Li S.Y.; Wu J.S.; Chung Y.C.; Li W.J.; Li Y.H.; Tang Y.C.; Shen K.H.; Lin W.Y.; Chen J.S.; Lee M.H.; Chen M.H.; Zou J.L.; Jhang J.S.; Syu J.S.; Yang S.S.; Chang S.J.; Lin A.T.L.; Fan Y.H.; Meng E.; Syu Y.J.; HONG-JENG YU; Guo Y.C.; Ye J.S.; Wang Y.J.; Jhang J.F.; Jiang Y.H.; Kuo H.C.; Team for National Registration of Ketamine Uropathy |
| 臺大學術典藏 |
2021-02-02T00:43:01Z |
Malignant ureteral obstruction: Functional duration of metallic versus polymeric ureteral stents
|
Chow P.-M.;Chiang I.-N.;Chen C.-Y.;Huang K.-H.;Hsu J.-S.;Wang S.-M.;Lee Y.-J.;Hong-Jeng Yu;Pu Y.-S.;Huang C.-Y.; Chow P.-M.; Chiang I.-N.; Chen C.-Y.; Huang K.-H.; Hsu J.-S.; Wang S.-M.; Lee Y.-J.; HONG-JENG YU; Pu Y.-S.; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010
|
Kuo H.-C.; Lin H.-H.; HONG-JENG YU; Cheng C.-L.; Hung M.-J.; Lin A.T.L.; Chang C.-H.; Chuang Y.-C.; Cha T.-L.; Chen G.-D.; Chen C.-S.; Wu M.-P.; Wu T.-L.; Yu K.-J.; Huang S.-T.; The Taiwan Mirabegron Study Team |
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
|
Kuo H.-C.;Lin H.-H.;Hong-Jeng Yu;Cheng C.-L.;Hung M.-J.;Lin A.T.L.; Kuo H.-C.; Lin H.-H.; HONG-JENG YU; Cheng C.-L.; Hung M.-J.; Lin A.T.L. |
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
Laparoendoscopic single-site (LESS) retroperitoneal partial adrenalectomy using a custom-made single-access platform and standard laparoscopic instruments: Technical considerations and surgical outcomes
|
Ho C.-H.;Liao P.-W.;Lin V.C.;Jaw F.-S.;Chueh S.-C.J.;Chung S.-D.;Liu S.-P.;Tsai Y.-C.;Hong-Jeng Yu; Ho C.-H.; Liao P.-W.; Lin V.C.; Jaw F.-S.; Chueh S.-C.J.; Chung S.-D.; Liu S.-P.; Tsai Y.-C.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
The Prevalence and the Risk Factors of Testosterone Deficiency in Newly Diagnosed and Previously Known Type 2 Diabetic Men
|
Ho C.-H.;Jaw F.-S.;Wu C.-C.;Chen K.-C.;Wang C.-Y.;Hsieh J.-T.;Hong-Jeng Yu;Liu S.-P.; Ho C.-H.; Jaw F.-S.; Wu C.-C.; Chen K.-C.; Wang C.-Y.; Hsieh J.-T.; HONG-JENG YU; Liu S.-P. |
| 臺大學術典藏 |
2021-02-02T00:43:03Z |
Laparoscopic radical prostatectomy monotherapy, a more aggressive yet less invasive option, is oncologically effective in selected men with high-risk prostate cancer having only one d'amico risk factor: Experience from an asian tertiary referral center
|
Tai H.-C.;Lai M.-K.;Huang C.-Y.;Wang S.-M.;Huang K.-H.;Chen C.-H.;Chung S.-D.;Chueh S.-C.J.;Hong-Jeng Yu;Pu Y.-S.; Tai H.-C.; Lai M.-K.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Chen C.-H.; Chung S.-D.; Chueh S.-C.J.; HONG-JENG YU; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:43:03Z |
Metallic ureteral stents in malignant ureteral obstruction: Clinical factors predicting stent failure
|
Chow P.-M.;Hsu J.-S.;Huang C.-Y.;Wang S.-M.;Lee Y.-J.;Huang K.-H.;Hong-Jeng Yu;Pu Y.-S.;Liang P.-C.; Chow P.-M.; Hsu J.-S.; Huang C.-Y.; Wang S.-M.; Lee Y.-J.; Huang K.-H.; HONG-JENG YU; Pu Y.-S.; Liang P.-C. |
| 臺大學術典藏 |
2021-02-02T00:43:04Z |
Hyposensitivity of C-fiber afferents at the distal extremities as an indicator of early stages diabetic bladder dysfunction in type 2 diabetic women
|
Lee W.-C.;Wu H.-C.;Huang K.-H.;Wu H.-P.;Hong-Jeng Yu;Wu C.-C.; Lee W.-C.; Wu H.-C.; Huang K.-H.; Wu H.-P.; HONG-JENG YU; Wu C.-C. |
| 臺大學術典藏 |
2021-02-02T00:43:04Z |
Metallic ureteral stents in malignant ureteral obstruction: Short-term results and radiological features predicting stent failure in patients with non-urological malignancies
|
Chow P.-M.;Hsu J.-S.;Wang S.-M.;Hong-Jeng Yu;Pu Y.-S.;Liu K.-L.; Chow P.-M.; Hsu J.-S.; Wang S.-M.; HONG-JENG YU; Pu Y.-S.; Liu K.-L. |
| 臺大學術典藏 |
2021-02-02T00:43:04Z |
Surgical management in enterovesical fistula in crohn disease at a single medical center
|
Su Y.-R.;Shih I.-L.;Tai H.-C.;Wei S.-C.;Lin B.-R.;Hong-Jeng Yu;Huang C.-Y.; Su Y.-R.; Shih I.-L.; Tai H.-C.; Wei S.-C.; Lin B.-R.; HONG-JENG YU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:05Z |
Osteoblast-derived WISP-1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126
|
Tai H.-C.;Chang A.-C.;Hong-Jeng Yu;Huang C.-Y.;Tsai Y.-C.;Lai Y.-W.;Sun H.-L.;Tang C.-H.;Wang S.-W.; Tai H.-C.; Chang A.-C.; HONG-JENG YU; Huang C.-Y.; Tsai Y.-C.; Lai Y.-W.; Sun H.-L.; Tang C.-H.; Wang S.-W. |
| 臺大學術典藏 |
2021-02-02T00:43:05Z |
Prediabetes Is Associated with an Increased Risk of Testosterone Deficiency, Independent of Obesity and Metabolic Syndrome
|
Ho C.-H.; HONG-JENG YU; Wang C.-Y.; Jaw F.-S.; Hsieh J.-T.; Liao W.-C.; Pu Y.-S.; Liu S.-P. |
| 臺大學術典藏 |
2021-02-02T00:43:06Z |
Association between Schizophrenia and Urinary Calculi: A Population-Based Case-Control Study
|
Liu S.-P.; Lin C.-C.; Lin H.-C.; Chen Y.-H.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:06Z |
Erratum: Anti-angiogenic effects and mechanism of prazosin (The Prostate (2011) 71 (976-984))
|
Liao C.-H.; Guh J.-H.; Chueh S.-C.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:06Z |
Alterations in peripheral purinergic and muscarinic signaling of rat bladder after long-term fructose-induced metabolic syndrome
|
Chung S.-D.; Chien C.-T.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:06Z |
Clear cell carcinoma of female urethral diverticulum-A case report
|
Weng W.-C.; Wang C.-C.; Ho C.-H.; Chang H.-C.; Chen S.-C.; HONG-JENG YU; Huang K.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:07Z |
Laparo-endoscopic single-site (LESS) bilateral nephroureterectomy for patients with end-stage renal disease
|
Chung S.-D.; Tsai Y.-C.; Wang S.-M.; Hung S.-F.; Huang C.-Y.; Chueh S.-C.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:07Z |
Quinolone prophylaxis in transrectal ultrasound guided prostate biopsy: An eight-year single center experience
|
Chiang B.-J.;Pu Y.S.;Chung S.-D.;Liu S.-P.;Hong-Jeng Yu;Wang S.-M.;Chang H.-C.;Chiang I.-N.;Huang C.-Y.; Chiang B.-J.; Pu Y.S.; Chung S.-D.; Liu S.-P.; HONG-JENG YU; Wang S.-M.; Chang H.-C.; Chiang I.-N.; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:08Z |
Penile veins are the principal component in erectile rigidity: A study of penile venous stripping on defrosted human cadavers
|
Hsu G.-L.; Hung Y.-P.; Tsai M.-H.; Hsieh C.-H.; Chen H.-S.; Molodysky E.; Huynh C.C.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:08Z |
Activating Nrf-2 Signaling Depresses Unilateral Ureteral Obstruction-Evoked Mitochondrial Stress-Related Autophagy, Apoptosis and Pyroptosis in Kidney
|
Chung S.D.; Lai T.Y.; Chien C.T.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:08Z |
Radiotherapy plus chemotherapy in muscle-invasive bladder cancer [1]
|
Chung S.-D.; Huang C.-Y.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:09Z |
A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer
|
Chen C.-H.; Yang H.-J.; Shun C.-T.; Huang C.-Y.; Huang K.-H.; HONG-JENG YU; Pu Y.-S. |
